188
Participants
Start Date
November 30, 2008
Primary Completion Date
October 31, 2010
Study Completion Date
August 31, 2014
Erlotinib
Continuous oral dosing at 150 mg daily.
PF-00299804
Continuous oral dosing at 45mg daily
National Taiwan University Hospital, Taipei
Taipei Veterans General Hospital, Chest Department, Taipei
Chris O'Brien Lifehouse, Camperdown
St. Vincent's Hospital, Fitzroy
The Andrew Love Cancer Centre,, Geelong
Border Medical Oncology, Wodonga
Hospital Teresa Herrera, A Coruña
Center for Blood and Cancer Disorders, Bethesda
Associates in Oncology/Hematology, PC, Rockville
Oncology/Hematology Associates, Clarksburg
Georgia Cancer Specialists, Decatur
Northwest Georgia Oncology Center, Marietta
Winship Cancer Institute at Grady Health Systems, Atlanta
Winship Cancer Institute at Emory University, Atlanta
Winship Cancer Institute of Emory University, Atlanta
Winship Cancer Institute, Emory University, Atlanta
The Longstreet Cancer Center, Gainesville
Augusta Oncology Associates, P.C., Augusta
Augusta Oncology Associates, PC, Augusta
Central Georgia Cancer Care, P.C., Macon
John B. Amos Cancer Center, Columbus
Northwest Alabama Cancer Center, Muscle Shoals
The West Clinic, Memphis
Hospital de Cruces, Barakaldo
University of Minnesota Cancer Center, Minneapolis
Midwestern Regional Medical Center, Zion
Kootenai Cancer Center at Post Falls, Post Falls
Kootenai Cancer Center, Post Falls
Agajanian Institute of Oncology and Hematology, Montebello
National Cancer Centre, Singapore
Bridgeport Hospital, Bridgeport
Wittingham Cancer Center @ Norwalk Hospital, Norwalk
Medical Oncology & Hematology, P.C., Waterbury
Winship Cancer Institute, Emory University, Atlanta
Central Georgia Cancer Care, P.C., Warner Robins
Irmandade da Santa Casa de Misericordia de Porto Alegre (ISCMPA) - Hospital Santa Rita, Porto Alegre
Hospital Sao Lucas da PUCRS, Porto Alegre
FUNDACAO PIO XII Hospital de Cancer de Barretos, Barretos
Instituto do Câncer do Estado de São Paulo Octavio Frias de Oliveira - ICESP, São Paulo
BC Cancer Agency - Vancouver Centre, Vancouver
Royal Victoria Hospital, Barrie
RSM Durham Regional Cancer Centre - Lakeridge Health Oshawa, Oshawa
The Ottawa Hospital Cancer Centre, Ottawa
Department of Clinical Oncology, Shatin
Department of Clinical Oncology, Tuen Mun Hospital, Tuenmen
Medex spolka cywilna, Chrzanów
¿KardioDent¿, Krakow
"Vesalius Sp. z o.o.", Krakow
Zaklad Rentgena i USG Wyrobek spolka jawna, Krakow
Niepubliczny Zaklad Opieki Zdrowotnej AVI Centrum Medyczne, Warsaw
Centrum Onkologii-Instytut im. Marii Sklodowskiej-Curie, Warsaw
Ponce School of Medicine / CAIMED Center, Ponce
Seoul National University Hospital, Seoul
Severance Hospital, Yonsei University College of Medicine, Yonsei Cancer Center, Seoul
SamsungMedicalCenter,SungkyunkwanUnivSchoolofMedicine,Div. of Hematology-Oncology, Dep. of Medicine, Seoul
Hospital Son Llatzer, Palma de Mallorca
Hospital Universitari Germans Trias I Pujol, Badalona
Christie Hospital NHS Foundation Trust, Manchester
Churchill Hospital, Oxford
Lead Sponsor
Pfizer
INDUSTRY